Intracellular delivery of nitric oxide enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction

Cell therapy by autologous mesenchymal stem cells (MSCs) is a clinically acceptable strategy for treating various diseases. Unfortunately, the therapeutic efficacy is largely affected by the low quality of MSCs collected from patients. Here, we showed that the gene expression of MSCs from patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Tian, Ji, Guangbo, Qian, Meng, Li, Qiu Xuan, Huang, Haoyan, Deng, Shiyu, Liu, Pei, Deng, Weiliang, Wei, Yongzhen, He, Ju, Wang, Shusen, Gao, Wenqing, Li, Tong, Cheng, Jiansong, Tian, Jinwei, Pan, Leiting, Gao, Fei, Li, Zongjin, Zhao, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686553/
https://www.ncbi.nlm.nih.gov/pubmed/38019911
http://dx.doi.org/10.1126/sciadv.adi9967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686553/
https://www.ncbi.nlm.nih.gov/pubmed/38019911
http://dx.doi.org/10.1126/sciadv.adi9967

Ejemplares similares